Anis Sahoo

Wonderful talk by @sahooanis who presented our recently published Cell Reports Medicine paper on surface #EV alpha-synuclein as an early #Parkinson’s biomarker at @UKEVSocc Forum 2025🔬 🔗doi.org/10.1016/j.xcrm… @NDCNOxford @KavliOxford

We showed that #Alzheimer-type pathology, measured by serum p-tau217, is already present in the prodromal phase of #Parkinson's and predicts risk of cognitive impairment or dementia. Co-pathology detection in early PD should be considered when testing precision therapies!

Delighted to share our latest @TofarisLab publication: Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behaviour Disorder onlinelibrary.wiley.com/doi/10.1002/an… #AnnalsofNeuro @ANA_journals @ShijunVictorYan @SahooAnis @NDCNOxford @KavliOxford

Huge congratulations to Anis Sahoo @SahooAnis for winning the Oxford 10k @raceforlife today!! 🏃🏽‍♂️✨ Incredible achievement, well done 🎉 🔗36:36 shorturl.at/EYD42

Neil Russell, a person with #Parkinson's, is running nonstop from Oxford to Cambridge! Together with @SahooAnis @TofarisLab we joined the first leg of Neil's challenge in the early hours starting @OUHospitals. Please RT or scan QR to support Neil's herculean task & @ParkinsonsUK

Another regular day in Tofaris Lab🧪! Post-docs Anis Sahoo, Taniya Bhardwaj, Andrew Castle and new DPhil student Joanna Komorowska were captured while working on iPSC-derived #Parkinson's samples, such as #EVs. @KavliOxford @NDCNOxford